Myanmar FDA Medical Device Registration: e-Submission and AMDD Class Guide

Quick answer

Myanmar regulates medical devices through the Department of Food and Drug Administration (FDA), Ministry of Health. While a dedicated Medical Device Act is still pending, FDA applies ASEAN Medical Device Directive (AMDD) risk classification (Class A–D) and administrative guidelines under the Public Health Law 1972. All medical device registration applications are submitted electronically via the FDA e-Submission System at https://esubmission.fda.gov.mm/. Foreign manufacturers must appoint a local authorized representative (AR) or registered Myanmar company to submit on their behalf. Dossiers typically include a Letter of Authorization (LoA), Free Sale Certificate (FSC), ISO 13485 quality system evidence, manufacturing licence or GMP documentation, and class-appropriate technical files. From 8 June 2026, portal login requires two-factor authentication (2FA).

Who this applies to

This guide applies to:

• Foreign medical device manufacturers exporting to Myanmar
• Local importers and distributors acting as authorized representatives
• Myanmar-registered companies submitting device applications in their own name
• Regulatory affairs teams mapping ASEAN AMDD classification to Myanmar FDA expectations

Device scope covers medical devices as defined under AMDD and FDA administrative practice—not standalone medicines, food products, or cosmetics (though the same e-submission portal handles multiple product categories).

Regulatory framework: Public Health Law 1972 and AMDD

Myanmar's FDA derives its authority over health products from the Public Health Law 1972, which establishes FDA oversight of pharmaceuticals, cosmetics, and medical devices. Unlike Thailand, Malaysia, or Singapore, Myanmar has not yet enacted a standalone Medical Device Act. In practice, FDA applies:

• ASEAN Medical Device Directive (AMDD, 2015) — risk-based classification and conformity assessment principles aligned with other ASEAN member states
• FDA administrative guidelines — procedural rules for registration, import control, and post-market obligations published through FDA communications and the e-submission portal

This transitional framework means manufacturers should expect AMDD-familiar dossier structures and Class A–D logic, while specific form fields and upload requirements are defined within the esubmission.fda.gov.mm medical device module rather than in a single consolidated public regulation.

AMDD device classification (Class A–D)

Myanmar FDA classifies medical devices using the AMDD four-tier risk framework:

Classification determines which documents FDA requests, review depth, and renewal or variation obligations. Confirm your AMDD class before preparing the dossier—misclassification is a common cause of query cycles and delays.

How to determine AMDD class

1. Identify the device's intended purpose and duration of contact with the body.
2. Assess invasiveness and whether the device is implantable or active.
3. Cross-reference AMDD classification rules and, where helpful, classification decisions in reference ASEAN markets (Thailand, Malaysia, Singapore) as supporting rationale—not as automatic acceptance.
4. Document the classification rationale in the technical file for FDA review.

Local authorized representative requirements

Foreign manufacturers cannot submit directly to Myanmar FDA without a local presence. A local authorized representative (AR)—typically a Myanmar-registered importer, distributor, or dedicated regulatory agent—must:

• Hold a valid company registration with Myanmar authorities (DICA registration for corporate entities)
• Execute a Letter of Authorization (LoA) naming the AR as the legal applicant and post-market contact
• Maintain the registered device listing and respond to FDA queries, recalls, or adverse event reports
• Submit applications, variations, and renewals through esubmission.fda.gov.mm under the AR's portal account

The AR is the legal face of the application in Myanmar. Foreign manufacturers remain responsible for product quality, technical documentation accuracy, and supply-chain compliance, but FDA correspondence flows through the AR.

FDA e-Submission portal (esubmission.fda.gov.mm)

The FDA e-Submission System at https://esubmission.fda.gov.mm/ is the official electronic channel for medical device registration, alongside food, drug, and cosmetic modules. Key portal characteristics:

• Unified login for multiple FDA product categories
• Medical device module with class-specific upload fields
• Application tracking and status visibility after submission
• Document upload for dossier components (PDF and formats as specified per field)
• Support channel — FDA publishes a Viber contact (09790800373) for portal assistance

Plan portal access early in your Myanmar market entry timeline. Account setup, identity verification, and 2FA configuration can take days before the first dossier upload.

Account registration: NRC, passport, and DICA

Before submitting a medical device application, the applicant (typically the local AR) must register a portal account:

Registration steps on esubmission.fda.gov.mm generally include:

1. Navigate to the portal homepage and select Register or Create Account.
2. Choose applicant category (individual citizen, company representative, etc.).
3. Upload scanned identity documents (NRC or passport) and company registration (DICA certificate where applicable).
4. Complete contact details — email and mobile number used for verification and 2FA.
5. Await account activation or verification confirmation from FDA before accessing the medical device submission module.

Keep NRC, passport, and DICA certificates current. Expired identity or company documents can block account renewal or variation submissions.

Two-factor authentication from June 2026

FDA announced that two-factor authentication (2FA) is mandatory for portal login from 8 June 2026. After this date:

• Username and password alone are insufficient for access
• Users must configure a second factor — typically an authenticator app or SMS/OTP method as offered on the portal
• All AR staff who submit or track applications need individual accounts with 2FA enabled

Action items before June 2026:

• Register backup contact methods in case the primary phone number changes
• Document 2FA recovery procedures in your quality or regulatory SOPs
• Ensure at least two authorised personnel per AR account can log in to avoid single-point-of-failure during urgent FDA queries

If your team manages multiple ASEAN FDA portals, treat Myanmar 2FA as a separate credential set—do not reuse passwords across jurisdictions.

Dossier requirements: LoA, FSC, ISO, and technical documentation

Myanmar FDA expects an AMDD-aligned dossier. While exact upload fields vary by class in the e-submission module, the following documents are consistently required or requested:

Letter of Authorization (LoA)

• Signed by the foreign manufacturer on company letterhead
• Names the local AR with full legal entity details
• Specifies device scope (product name, model, manufacturer address)
• Defines AR responsibilities for registration, import, and post-market reporting
• Notarised or legalised if FDA requests authenticated copies

Free Sale Certificate (FSC) / Certificate of Export

• Issued by the competent authority in the country of manufacture (e.g., FDA US, MHRA, HSA, TGA)
• Confirms the device is freely sold in the home market
• Must match the same product and manufacturer named in the application
• Typically valid within 12 months of issue—check FDA's current acceptance window

ISO 13485 quality management certificate

• Certificate for the manufacturing site covering the device scope
• Issued by an accredited certification body
• Include the scope statement page showing the product category
• If multiple manufacturing sites exist, each relevant site may need separate QMS evidence

Manufacturing licence and GMP evidence

• Manufacturing licence from the country of origin
• GMP inspection report or certificate where available
• For contract manufacturers, include the subcontractor's licence and a flow-down quality agreement summary

Technical documentation (class-dependent)